Malat1 promotes macrophage-associated inflammation by increasing PPAR-γ methylation through binding to EZH2 in acute myocardial infarction

Int Immunopharmacol. 2023 Oct:123:110695. doi: 10.1016/j.intimp.2023.110695. Epub 2023 Aug 15.

Abstract

The inflammatory microenvironment of macrophage plays an important role in acute myocardial infarction (AMI), but the regulatory mechanism is unknown. Here, we aimed to investigate the role of Malat1 on inflammation microenvironment of macrophage in AMI. Our study found that Malat1 expression was increased in AMI, which mainly expressed in macrophages. Malat1 inhibition improved collagen deposition and inflammation in infarcted heart. In vitro, Malat1 inhibition evidently reduced macrophage-associated inflammation. The results from ribonucleic acid pull-down (RNA pull-down) and RNA Immunoprecipitation (RIP) assay demonstrated that Malat1 directly binds to EZH2. Malat1 and EZH2 complex could increase histone H3K27me3 expression and further inhibit the production of PPAR-γ. In vivo, inhibition of Malat1 also leaded to the down-regulation of both EZH2 and H3K27me3, as well as up-regulation of PPAR-γ in infarcted heart. Therefore, these findings demonstrate a novel mechanism of Malat1 on inflammation microenvironment of macrophage in AMI, which provide a new target for its treatment.

Keywords: Acute myocardial infarction; Epigenetic modification; Inflammatory microenvironment; Long non-coding RNA; Macrophages.

MeSH terms

  • Enhancer of Zeste Homolog 2 Protein / genetics
  • Histones
  • Humans
  • Inflammation
  • Macrophages
  • Methylation
  • Myocardial Infarction* / genetics
  • PPAR gamma*
  • RNA

Substances

  • PPAR gamma
  • Histones
  • RNA
  • EZH2 protein, human
  • Enhancer of Zeste Homolog 2 Protein